首页> 外国专利> PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OSTEOPOROSIS, COMPRISING ANALOGS OF PARATHYROID HORMONE AND PARATHYROID HORMONE RELATED PEPTIDE

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OSTEOPOROSIS, COMPRISING ANALOGS OF PARATHYROID HORMONE AND PARATHYROID HORMONE RELATED PEPTIDE

机译:用于治疗骨质疏松症的药物组合物,包括类比拟甲状旁腺激素和类比拟甲状旁腺激素相关肽

摘要

Synthetic polypeptide analogs of parathyroid hormone PTH, parathyroid hormone related peptide PTHrp, and of the physiologically active truncated homologs and analogs of PTH and PTHrp, in which amino acid residues (22-31) form an amphipathic alpha -helix, said residues (22-31) selected from hydrophilic amino acids (Haa) and lipophilic amino acids (Laa) ordered in the sequence: Haa(Laa Laa Haa Haa)2 Laa and their pharmaceutically acceptable salts are useful for the prophylaxis and treatment of ostoporosis in mammals. Processes for the production of the polypeptides via solid phase and recombinant methods are provided.
机译:甲状旁腺激素PTH,甲状旁腺激素相关肽PTHrp以及具有生理活性的截短同源物的合成多肽类似物以及PTH和PTHrp的类似物,其中氨基酸残基(22-31)形成两亲性α-螺旋,所述残基(22- 31)选自亲水氨基酸(Haa)和亲脂性氨基酸(Laa)的序列:Haa(Laa Laa Haa Haa)2 Laa及其药学上可接受的盐可用于预防和治疗哺乳动物的骨质疏松症。提供了通过固相和重组方法生产多肽的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号